Professor of Infectious Diseases and Head of the Laboratory Alerta at the Division of Infectious Diseases, Department of Internal Medicine at Escola Paulista de Medicina, Universidade Federal de São Paulo, Brazil. Dr. Gales’ research has been focused on the molecular epidemiology of multi-drug resistant bacteria and study of mechanisms of bacterial resistance to clinically significant antimicrobials. Dr. Gales is a full member of the Technical Chamber on Microbial Resistance in Health Services (CATREM), with the purpose of advising the Brazilian Health Surveillance Agency (ANVISA) in establishing standards and measures for monitoring, control, and prevention of antimicrobial resistance in Brazilian health services. She served as Chair of the Brazilian Committee on Antimicrobial Susceptibility (BrCAST, 2017-2018). She is also an editor for mSphere®, and associate editor for The BrazilianJournal of Infectious Diseases, and the Journal of Global Antimicrobial Resistance.

Currículo Lattes

http://lattes.cnpq.br/8402272715765172

Frente (s) de trabalho

Bioexperimentação e Fisiopatologia
Eixo: Mudanças Climáticas - Saúde e Meio Ambiente
Inovação Farmacêutica e Diagnóstica
Observatório clínico e social envolvendo interação com vigilância epidemiológica, organização de coortes, data science e mídias sociais

Linhas de Pesquisa

My research has been mainly focused on the evaluation of the in vitro activity of new antimicrobials, detection of bacterial resistance mechanisms and development of new diagnostic methods for detection of resistant bacteria in distinct environments.

Palavras chaves de pesquisa

Bacterial Resistance; antimicrobials, bacteria; gram-negative bacilli; One-Health

Projetos

1. Pilot-Study for Implementation of a Brazilian Network on Antimicrobial Resistance Based on One-Health Perspective (402659/2018-0) - Principal investigator - Financial support: CNPq.

2. Evaluation of Antimicrobial Activity of Delafloxacin against Pathogens of Clinical Importance - Principal investigator - Financial support: Eurofarma.

3. Development of an Immunochromatographic Test for Detection of Carbapenemases In Enterobacterales (2021/01158-3) - Financial support: FAPESP.